Canada Goose (GOOS) Exceeds Market Returns: Some Facts to Consider

Canada Goose (GOOS) recently closed at $12.06, up 1.52% and outpacing the S&P 500, though its monthly performance trailed broader market and sector indices. The company is expected to report a Q-on-Q EPS decline of 5.17% to -$0.61 on a 3.99% revenue increase to $66.96 million, while full fiscal year estimates project EPS growth of 10% to $0.88 and revenue growth of 2.89% to $1 billion. GOOS holds a Zacks Rank of #2 (Buy) and trades at a Forward P/E of 13.58 and a PEG ratio of 0.75, both representing a discount to industry averages, despite its industry being ranked in the bottom 22%.

Analysis

Canada Goose (GOOS) displays a mixed but compelling profile for investors. The stock recently outperformed major indices with a 1.52% daily gain, yet its one-month performance of 1.54% has lagged both its Retail-Wholesale sector and the S&P 500. The immediate outlook is bifurcated; while upcoming quarterly revenue is forecast to rise 3.99% YoY to $66.96 million, earnings per share are expected to decline 5.17% to -$0.61. This near-term profitability pressure contrasts with a more optimistic full-year projection, which calls for 10% EPS growth and 2.89% revenue growth. Despite stagnant consensus EPS estimates over the past month, the stock holds a Zacks Rank of #2 (Buy). This is supported by valuation metrics that suggest a potential discount; its Forward P/E of 13.58 is below the industry average of 17.55, and a PEG ratio of 0.75 is significantly more attractive than the industry's 1.81. However, a significant headwind exists as the company operates within the Retail - Apparel and Shoes industry, which ranks in the bottom 22% of over 250 industries, indicating broad sectoral weakness.

Key Decisions for Investors

• Given the stock's attractive valuation, with a Forward P/E of 13.58 and a PEG ratio of 0.75, investors may find the current price a compelling entry point, particularly if they are aligned with the positive full-year growth forecasts.
• Investors should closely monitor the upcoming earnings report, as a worse-than-expected EPS decline could amplify near-term profitability concerns and potentially override the stock's positive analyst rating and valuation case.
• It is crucial to weigh the company-specific strengths, such as its Zacks #2 (Buy) rank, against the significant headwind of its industry's poor ranking; portfolio allocation should consider if GOOS can outperform despite broad sector weakness.